{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-06-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Ineligible",
      "product_code": "QDL",
      "openfda": {
        "k_number": [
          "K182405"
        ],
        "registration_number": [
          "2024024"
        ],
        "fei_number": [
          "2024024"
        ]
      },
      "review_panel": "CH",
      "medical_specialty": "CH",
      "device_name": "Integrated Continuous Glucose Monitoring System For Professional Retrospective Use",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Clinical Chemistry",
      "device_class": "2",
      "definition": "An integrated continuous glucose monitoring system for professional retrospective use is a continuous glucose recording device indicated for the retrospective discovery, analysis, and interpretation of glycemic variability in persons age 2 and older for use by healthcare professionals to guide appropriate patient management.  The system is also intended to interface with digitally connected devices.",
      "regulation_number": "862.1355",
      "implant_flag": "N",
      "submission_type_id": "1"
    }
  ]
}